Modern Practice Principles in Lung Cancer Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide for 2024 The One-Stop Resource for Community-Based Oncology Professionals on Biomarker Testing and Targeted Therapies
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/TFK
- Start Date: 2024-06-02 05:00:00
- End Date: 2024-06-02 05:00:00
- Credit Details: IPCE Credits: 1.5 hours
AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABIM - 1.5 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: Source: AstraZeneca (Any division) - Amount: 9123.0 - Is Kind Support: False Source: Bristol-Myers Squibb Company - Amount: 18005.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 12004.0 - Is Kind Support: False Source: Lilly (Any division) - Amount: 22807.0 - Is Kind Support: False Source: Novartis Corporation Pharmaceuticals - Amount: 30009.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest